Intravenous prostacyclin in the treatment of persistent pulmonary hypertension of the newborn refractory to inhaled nitric oxide.
Department of Neonatology, Division of Pediatrics, Hadassah University Hospital, Mt. Scopus, Jerusalem, Israel.
Elena
E
Golzand
Benjamin
B
Bar-Oz
Ilan
I
Arad
D000280:Administration, Inhalation; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D045462:Endothelium-Dependent Relaxing Factors / Q000627:therapeutic use; D011464:Epoprostenol / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D007262:Infusions, Intravenous; D008297:Male; D009569:Nitric Oxide / Q000627:therapeutic use; D010547:Persistent Fetal Circulation Syndrome / Q000188:drug therapy*
D000959:Antihypertensive Agents; D045462:Endothelium-Dependent Relaxing Factors; D009569:Nitric Oxide; D011464:Epoprostenol